Fox Business - The Power to Prosper
Search Site

Abbott Laboratories

Abbott Laboratories 1Q earnings

Earnings HQ: FBN’s Jo Ling Kent breaks down Abbott Laboratories ’ first-quarter earnings report.

Read More

  1. Can stocks like Abbott Labs benefit from ObamaCare?

    Glenmede Director of Investment Strategy Jason Pride and Green Square Capital Managing Director Lincoln Ellis on the outlook for the markets and the impact of regulations on the financial sector.

  2. Difficult to find value stocks in this market?

    Fairfax Global Markets CEO Paul Dietrich and Swan Wealth Advisors’ Mark Sebastian offer tips for investing in this market environment.

  3. HHS Secretary testifies on ObamaCare rollout

    FBN’s Rich Edson on HHS Secretary Kathleen Sebelius’ testimony on the rollout of ObamaCare and the law’s impact on health sector stocks.

  4. AbbVie beats forecast as Humira sales surge

    AbbVie Inc on Friday reported stronger-than-expected results for the third quarter, as booming sales of its Humira arthritis treatment and Synthroid thyroid replacem...

  5. Detecting Malaria Using an Electric Vibe

    Hundreds of thousands of children die from malaria each year with about half of the world's population at risk of the disease at any given time, but new research has...

  6. Abbott Laboratories Reports Higher Quarterly Profits

    Abbott Laboratories reported better than expected quarterly earnings despite disrupted sales of its infant formulas in China, helped by cost cuts and lower taxes.The...

  7. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Despite the technical difficulties and the government shutdown, the Affordable Care Act has launched in most states with others soon to follow.Primary beneficiaries ...

  8. Eyes online, milk powder firms count cost of China probes

    Global milk powder firms are scrutinizing Chinese social media reports up to four times a day to gauge consumer reaction to a high-profile pricing probe and food saf...

  9. Medical Device Makers to Discuss Cyber Threat

    Two months after drug safety regulators urged medical device manufacturers to stay alert to the risk of cyber attacks, one prominent security group said it's partner...

  10. Mead Johnson settles with China over baby formula probe

    Mead Johnson Nutrition Co said on Tuesday it would pay a penalty of about $33 million related to a probe by China into possible price fixing and anti-competitive pra...

  11. The 3 Stocks to Help Investors Beat the Markets

    Barron’s Senior Editor Jack Hough on the stocks investors should consider for their portfolios.

  12. Three Soaring, But Overlooked Health Care ETFs

    This has been an excellent year in which to be long the health care sector.The Health Care Select Sector SPDR (NYSE:XLV) and the Vanguard Health Care ETF (NYSE:VHT) ...

  1. Abbott Beats Profit Forecast, But Sales Lag

    Abbott Laboratories Inc reported better-than-expected quarterly earnings, but sales came in slightly below Wall Street expectations.The company on Wednesday said it ...

  2. Stocks to watch: MSFT, ABT

    Glenmede Director of Investment Strategy Jason Pride, Janney Capital Markets Technical Research Director Dan Wantrobski and Altimus Capital Director of Portfolio Management Chris Gersch on the stocks to boost investors’ portfolios.

  3. Novartis CEO Reshapes Firm For 'Brutal' New World

    Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new ...

  4. Stocks to boost your portfolio

    Ace Investment Strategists Chief Trader Yu-Dee Chang, Glenmede Director of Investment Strategy Jason Pride and Altimus Capital’s Chris Gersch on the investing opportunities in the markets.

  5. Dan Loeb Takes Stakes In BlackBerry, T-Mobile

    Third Point, headed by billionaire fund manager Dan Loeb, has put more money into struggling mobile device makers. According to a 13-f filing released late Friday by...

  6. 'Big potential' stock picks

    Matthew Vetto of Douglas C. Lane & Associates gives insight into the markets.

  7. Abbott Misses Top Line Views in the Fourth Quarter

    Abbott Laboratories Inc reported weaker-than-expected fourth-quarter revenue, hurt by the stronger dollar and an overseas sales disruption last summer of its baby fo...

‹ Prev12345Next ›
Freebase CC-BY
Source: Abbott Laboratories on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL